Loading...
Loading...
Browse all stories on DeepNewz
VisitEdwards Lifesciences to Sell Critical Care Unit to Becton Dickinson for $4.2 Billion in Cash
Jun 3, 2024, 12:26 PM
Edwards Lifesciences has agreed to sell its critical care products unit to Becton Dickinson for $4.2 billion in an all-cash transaction. The move is aimed at allowing Edwards Lifesciences to focus more on its heart devices business. Becton Dickinson, also known as BD, plans to expand its portfolio of smart medical monitoring and patient monitoring products through this acquisition. The deal was announced on Monday, June 3, 2024, and has positively impacted the stock prices of both companies, with BDX up 2.2% and EW up 3.6% in pre-market trading.
View original story
Markets
No • 50%
Yes • 50%
Official press releases from Edwards Lifesciences or Becton Dickinson, financial news reports
No • 50%
Yes • 50%
Stock price data from financial markets
No • 50%
Yes • 50%
Stock price data from financial markets
Increase by more than 10% • 33%
Decrease • 33%
Increase by less than 10% • 33%
Stock price data from financial markets
No significant change • 33%
Increase by less than 5% • 33%
Increase by more than 5% • 33%
Market capitalization data from financial markets
Not approved • 33%
Approved without conditions • 33%
Approved with conditions • 33%
Official announcements from regulatory bodies, Edwards Lifesciences, or Becton Dickinson